Showing results (1021-1030 of 1,073) with videos related to
Sort By:
Pageof 108
British Journal of Clinical Pharmacology|July 1, 2026
Case-malformed signal detection and prioritisation using EUROmediCAT data for pharmacovigilance in pregnancyHannah Johnson, Helen Dolk, Maria Loane, et al.Plos One|August 30, 2023
Creating a population-based cohort of children born with and without congenital anomalies using birth data matched to hospital discharge databases in 11 European regions: Assessment of linkage success and data qualityMaria Loane, Joanne E Given, Joachim Tan, et al.Journal of Hepatology|December 13, 2022
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitisLung-Yi Mak, Ed Gane, Christian Schwabe, et al.British Journal of Clinical Pharmacology|March 31, 2016
EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associationsJoanne E Given, Maria Loane, Johannes M Luteijn, et al.Plos One|July 22, 2022
Hospital length of stay among children with and without congenital anomalies across 11 European regions-A population-based data linkage studyStine Kjaer Urhoj, Joachim Tan, Joan K Morris, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2021
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN StudyKim N Chi, Simon Chowdhury, Anders Bjartell, et al.Journal of Hepatology|July 23, 2022
Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHBMan-Fung Yuen, Stephen Locarnini, Tien Huey Lim, et al.The Journal of Urology|June 10, 2026
Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and ToxicityArvin George, Eric Giesler, Brian Mazzarella, et al.Prostate Cancer and Prostatic Diseases|November 2, 2025
DARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: prespecified third interim analysisEvan Y Yu, Hiroyoshi Suzuki, Christopher M Pieczonka, et al.Pediatrics|February 11, 2022
Ten-Year Survival of Children With Congenital Anomalies: A European Cohort StudySvetlana V Glinianaia, Judith Rankin, Anna Pierini, et al.Pageof 108